Clinical trial · Observational
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
NCT06980792CI-TRIAL-00089932completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study focuses on patients with synchronous liver metastasis from pancreatic adenocarcinoma that underwent both pancreatic and liver resection. The control group is made up of patients with resectable or borderline resectable pancreatic adenocarcinoma and synchronous liver metastasis that were excluded from surgery. Short and long-term outcomes will be compared to evaluate the safety and efficacy of simultaneous liver and pancreatic resection.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Metastasis | — | UNRESOLVED | — |
| Liver Resection | — | UNRESOLVED | — |
| Pancreas Ductal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | ALIAS | 0.90 |
| Pancreas Neoplasms | Pancreatic Neoplasm | ALIAS | 0.90 |
| Pancreatectomy | — | UNRESOLVED | — |
| Surgery of the Pancreatic Head | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy | Drug | Chemotherapy | ALIAS |
| Pancreatectomy and liver resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Surgical group
- description
- Patients that underwent pancreatic and liver surgery
- interventionNames
- Procedure: Pancreatectomy and liver resection
- label
- Non-surgical group
- description
- Patients that underwent CHT alone
- interventionNames
- Drug: Chemotherapy
Primary outcomes (2)
- measure
- Overall survival
- timeFrame
- 3 years
- measure
- Recurrence-free survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients of age \>18, underwent surgery for pancreatic adenocarcinoma (duodenopancreatectomy, distal pancreatectomy, total pancreatectomy) and liver resection (major or minor) for synchronous metastasis, that received neoadjuvant and/or adjuvant chemotherapy. * The control group is made up of patients age \>18 with resectable or borderline resectable pancreatic adenocarcinoma and synchronous liver metastasis that didn't underwent surgery.
References
Publications (0)
Data not yet available
No reference posted for this study.